United States cardiology surgical and interventional devices market is expected to witness healthy CAGR during the forecast period. Key factors fueling the growth of United States cardiology surgical and interventional devices market include continuous
Additionally, advancements in medical devices have led to introduction of bioabsorble stents and new generation celect platinum IVC (inferior vena cava) filter, which are gaining huge traction in United States cardiology surgical and interventional devices market. The country is also witnessing rising prevalence of cardiovascular diseases, which is acting as one of the major factors behind growing demand for cardiology surgical and interventional devices.
United States cardiology surgical and interventional devices market can be categorized based on
Major players operating in the United States cardiology surgical and interventional devices market include Biosense Webster, Inc., Boston Scientific Corporation, C.R. Bard, Inc., Edwards Lifesciences Corp., Medtronic. Inc., Cardinal Health Inc., Abbott Laboratories Inc., Terumo Medical Corporation, Becton Dickinson and Company and Johnson & Johnson, among others. The companies are investing on launching novel products and are undertaking growth strategies such as mergers & acquisitions and collaborations.
Objective of the Study
- To analyze and estimate the market size of United States cardiology surgical and interventional devices market from 2017 to 2020.
- To estimate and forecast the market size of United States cardiology surgical and interventional devices market from 2021 to 2027 and growth rate until 2027.
- To classify and forecast United States cardiology surgical and interventional devices market based on product type, surgical approach, type of cardiac surgery, end user, company and regional distribution.
- To identify dominant region or segment in the United States cardiology surgical and interventional devices market.
- To identify drivers and challenges for United States cardiology surgical and interventional devices market.
- To examine competitive developments such as expansions, mergers & acquisitions, etc., in United States cardiology surgical and interventional devices market.
- To conduct pricing analysis for United States cardiology surgical and interventional devices market.
- To identify and analyze the profile of leading players operating in United States cardiology surgical and interventional devices market.
- To identify key sustainable strategies adopted by market players in United States cardiology surgical and interventional devices market.
Click here to download the sample
Market insights research performed both primary as well as exhaustive secondary research for this study. Initially, Market insights research sourced a list of cardiology surgical and interventional device manufacturers across United States. Subsequently, Market insights research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, Market insights research could include the manufacturers who could not be identified due to the limitations of secondary research. Market insights research analyzed the presence of all major players across United States.
Market insights research calculated the market size of
Key Target Audience
- Cardiology surgical and interventional devices manufacturers, suppliers, distributors and other stakeholders
- Government bodies such as regulating authorities and policy makers
- Organizations, forums and alliances related to cardiology surgical and interventional devices
- Market research and consulting firms
The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as cardiology surgical and interventional device manufacturers, suppliers, partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.
| Attribute | Details |
| Base Year | 2021 |
| Historical Years | 2017 – 2020 |
| Estimated Year | 2022E |
| Forecast Period | 2023F – 2027F |
| Quantitative Units | Revenue in USD Million, and CAGR for 2017-2021 and 2022E-2027F |
| Report Coverage | Revenue forecast, company share, competitive landscape, growth factors, and trends |
| Segments Covered | - Type
- Surgical Approach
- Type of Cardiac Surgery
- End User
|
| Region Scope | South-Region, West-Region, Mid-West Region & Northeast-Region |
| Key Companies Profiled | Biosense Webster, Inc., Boston Scientific Corporation, C.R. Bard, Inc., Edwards Lifesciences Corp., Medtronic. Inc., Cardinal Health Inc., Abbott Laboratories Inc., Terumo Medical Corporation, Becton Dickinson and Company and Johnson & Johnson. |
| Customization Scope | 10% free report customization with purchase. Addition or alteration to regional & segment scope. |
| Pricing and Purchase Options | Avail customized purchase options to meet your exact research needs. Explore purchase options |
| Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
